Evaluation of tumor necrosis factor-α, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Philippe Erard, François Robert-Grandpierre, Pierre Kaeser

Circulating levels of sTNFR and discrepancy between cytotoxicity and immunoreactivity of TNF-α in patients with visceral leishmaniasis I.M. Medeiros,

Philippe Brouqui, Didier Raoult, Jean Marc Durand

Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study Dominique S.

Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute.

Approach to diagnosis of infective endocarditis

C-reactive protein as a marker of infection in critically ill patients

Herpes zoster in non-hospitalized children

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Atypical respiratory pathogens

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gastroenteritis outbreak caused by norovirus associated with the children's club of a hotel located in Majorca, Spain A. Doménech-Sánchez Clinical Microbiology.

R. Cantón Clinical Microbiology and Infection

Hydatid disease Clinical Microbiology and Infection

Link between intracellular pathogens and cardiovascular diseases

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Evaluation of Th1/Th2 cytokines as a rapid diagnostic tool for severe infection in paediatric haematology/oncology patients by the use of cytometric bead.

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia F.M. Brunkhorst, B. Al-Nawas, F. Krummenauer,

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Leucocyte esterase, glucose and C-reactive protein in the diagnosis of prosthetic joint infections: a prospective study E. De Vecchi, F. Villa, M. Bortolin,

Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia S.-C. Kuo, Y.-T. Lee,

Cephalosporins: a pharmacological update

Retrospective study of CMV retinitis in patients with AIDS

Epidemiology of opportunistic infections in AIDS patients

Laboratory diagnosis and biosafety issues of biological warfare agents

Sepsis and neutropenia induced by clozapine

Uncommon opportunistic fungi: new nosocomial threats

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease Inge O. Baas, G. Johan A. Offerhaus, Ralph.

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Training in infectious diseases and tropical medicine in Britain

Fibronectin concentrations in catheter sepsis

Clinical infection services—the Leiden experience

Ethan Rubinstein, Itzhak Levy Clinical Microbiology and Infection

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

Statin use and clinical outcomes among pneumonia patients

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis Miles Denton, Kevin G Kerr, Fraser Lewis Clinical.

Clinical Microbiology and Infection

Empiric therapy of bacterial infections in severe neutropenia

W. Eugene Sanders, Christine C. Sanders

Evaluation of the performance of the Helico Blot 2

Overview of cefixime use in community-acquired infections

Granulocyte colony-stimulating factor (G-CSF) and interleukin (IL)-8 in sera from patients with Staphylococcus aureus septicemia Bo Söderquist, Dan Danielsson,

Lymphocyte subset numbers depend on the bacterial origin of sepsis

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Localized Mycobacterium avium complex infection in a patient on HAART

The future of diagnostic bacteriology

Assessment of the BacT/Alert blood culture system: rapid bacteremia diagnosis with loading throughout the 24 h Jonas Bengtsson, Martin Wahl, Peter Larsson

Vincent Calvez, Marc Grandadam Clinical Microbiology and Infection

Presentation transcript:

Evaluation of tumor necrosis factor-α, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of sepsis without shock Baudouin Byl, Jacques Devière, Francis Saint-Hubert, Francis Zech, Béatrice Gulbis, Jean-Pierre Thys Clinical Microbiology and Infection Volume 3, Issue 3, Pages 306-313 (June 1997) DOI: 10.1111/j.1469-0691.1997.tb00618.x Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Interleukin-6, tumor necrosis factor-α and C-reactive protein relative operating characteristic (ROC) curves. Clinical Microbiology and Infection 1997 3, 306-313DOI: (10.1111/j.1469-0691.1997.tb00618.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 IL-6 plasma levels of the three groups of patients with septic signs onset <24 h. Clinical Microbiology and Infection 1997 3, 306-313DOI: (10.1111/j.1469-0691.1997.tb00618.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 TNF-α plasma levels of the three groups of patients with septic signs onset <24 h. Clinical Microbiology and Infection 1997 3, 306-313DOI: (10.1111/j.1469-0691.1997.tb00618.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 4 CRP plasma levels of the three groups of patients with septic signs onset <24 h. Clinical Microbiology and Infection 1997 3, 306-313DOI: (10.1111/j.1469-0691.1997.tb00618.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions